Free tool
FAERS Monitor: Fluorescein Sodium and Benoxinate Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 211039 or its brand name (Fluorescein Sodium and Benoxinate Hydrochloride, Benoxinate Hydrochloride, Fluorescein Sodium). Reports on generic versions are filed under their own applications.
Reports
3
Serious
3
100% of reports
Hospitalization
0
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- syncope2
- abdominal pain upper1
- blood glucose decreased1
- confusional state1
- disorientation1
- dizziness1
- dysarthria1
- dyspnoea1
- fatigue1
- feeling hot1
- headache1
- heart rate increased1
- hydronephrosis1
- hypotension1
- lower respiratory tract congestion1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2024 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,156 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| lower respiratory tract congestion | 1 | 4125.8 | 832.1 | 1,030 |
| hydronephrosis | 1 | 936.5 | 189.0 | 233 |
| dysarthria | 1 | 186.2 | 37.6 | 46 |
| disorientation | 1 | 177.0 | 35.7 | 43 |
| blood glucose decreased | 1 | 146.0 | 29.5 | 36 |
| syncope | 2 | 140.1 | 63.0 | 155 |
| feeling hot | 1 | 114.4 | 23.1 | 28 |
| heart rate increased | 1 | 70.8 | 14.3 | 17 |
| confusional state | 1 | 43.4 | 8.8 | 10 |
| hypotension | 1 | 35.0 | 7.1 | 8 |
| abdominal pain upper | 1 | 34.1 | 6.9 | 8 |
| dizziness | 1 | 14.1 | 2.8 | 3 |
| dyspnoea | 1 | 12.4 | 2.5 | 2 |
| headache | 1 | 11.2 | 2.3 | 2 |
| fatigue | 1 | 9.0 | 1.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.